相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination therapies with daclatasvir and asunaprevir on NS3-D168 mutated HCV in human hepatocyte chimeric mice
Hiromi Kan et al.
ANTIVIRAL THERAPY (2016)
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice
Jannick Prentoe et al.
GUT (2016)
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
Paula M. Perin et al.
HEPATOLOGY (2016)
Naturally occurring HCV NS5A/B inhibitor resistance-associated mutations to direct-acting antivirals
Linh Thuy Nguyen et al.
ANTIVIRAL THERAPY (2016)
Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection
Yoshitaka Shirasago et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies
Catherine Fauvelle et al.
GASTROENTEROLOGY (2016)
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Jean-Michel Pawlotsky
GASTROENTEROLOGY (2016)
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
Christoph Sarrazin
JOURNAL OF HEPATOLOGY (2016)
Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice
Takuro Uchida et al.
VIRUS RESEARCH (2016)
Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment
Sabrina Bagaglio et al.
VIRUSES-BASEL (2016)
Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein
Jeffrey J. Pouliot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Randomized Trial of Interferon- and Ribavirin-Free Ombitasvir/Paritaprevir/Ritonavir in Treatment-Experienced Hepatitis C Virus-Infected Patients
Kazuaki Chayama et al.
HEPATOLOGY (2015)
Hepatitis C virus drug resistance-associated substitutions: State of the art summary
Erik Lontok et al.
HEPATOLOGY (2015)
HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b
Yosuke Hirotsu et al.
HEPATOLOGY INTERNATIONAL (2015)
Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model
Sara Calattini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort
Samantha J. Shepherd et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice
Yugo Kai et al.
JOURNAL OF GASTROENTEROLOGY (2015)
TARGETING A HOST-CELL ENTRY FACTOR BARRICADES ANTIVIRAL RESISTANT HCV VARIANTS FROM ON-THERAPY BREAKTHROUGH IN HUMAN-LIVER MICE
K. Vercauteren et al.
JOURNAL OF HEPATOLOGY (2015)
Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies
Oliver Lenz et al.
JOURNAL OF HEPATOLOGY (2015)
Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV
Tania Silva et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy
Satoshi Yoshimi et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action
Noemie Calland et al.
JOURNAL OF VIROLOGY (2015)
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Masashi Mizokami et al.
LANCET INFECTIOUS DISEASES (2015)
Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A
Jin-Hua Sun et al.
NATURE (2015)
Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody
Laurent Mailly et al.
NATURE BIOTECHNOLOGY (2015)
Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin
Vanesa Madan et al.
VIRUSES-BASEL (2015)
In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
Soren Ottosen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection
Gaspar Lisboa-Neto et al.
ANTIVIRAL THERAPY (2015)
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C
Tanya L. Applegate et al.
ANTIVIRAL THERAPY (2015)
Clinical Evidence and Bioinformatics Characterization of Potential Hepatitis C Virus Resistance Pathways for Sofosbuvir
Eric F. Donaldson et al.
HEPATOLOGY (2015)
Global Distribution and Prevalence of Hepatitis C Virus Genotypes
Jane P. Messina et al.
HEPATOLOGY (2015)
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1
K. Kosaka et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Hepatitis C Virus Core Protein Suppresses Mitophagy by Interacting with Parkin in the Context of Mitochondrial Depolarization
Yuichi Hara et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Human Hepatocytes and Hematolymphoid Dual Reconstitution in Treosulfan-Conditioned uPA-NOG Mice
Tanuja L. Gutti et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance- Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors
V. C. Di Maio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Update on hepatitis C virus resistance to direct-acting antiviral agents
Eva Poveda et al.
ANTIVIRAL RESEARCH (2014)
Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure
Malcolm J. Macartney et al.
ANTIVIRAL RESEARCH (2014)
Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients
Meike H. van der Ree et al.
ANTIVIRAL RESEARCH (2014)
Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice
Jizheng Chen et al.
CELL RESEARCH (2014)
Formulated Minimal-Length Synthetic Small Hairpin RNAs Are Potent Inhibitors of Hepatitis C Virus in Mice With Humanized Livers
Han Ma et al.
GASTROENTEROLOGY (2014)
Cyclophilin Inhibitors Reduce Phosphorylation of RNA-Dependent Protein Kinase to Restore Expression of IFN-Stimulated Genes in HCV-Infected Cells
Takuji Daito et al.
GASTROENTEROLOGY (2014)
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
Anggakusuma et al.
GUT (2014)
Cell Entry, Efficient RNA Replication, and Production of Infectious Hepatitis C Virus Progeny in Mouse Liver-Derived Cells
Anne Frentzen et al.
HEPATOLOGY (2014)
Successful Anti-Scavenger Receptor Class B Type I (SR-BI) Monoclonal Antibody Therapy in Humanized Mice After Challenge With HCV Variants With In Vitro Resistance to SR-BI-Targeting Agents
Koen Vercauteren et al.
HEPATOLOGY (2014)
HCV animal models and liver disease
Koen Vercauteren et al.
JOURNAL OF HEPATOLOGY (2014)
Natural Prevalence of Hepatitis C Virus (HCV) Variants Resistant to Protease and Polymerase Inhibitors in Patients Infected With HCV Genotype 1 in Tunisia
Jameleddine Aissa Larousse et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
Inhibition of Hepatitis C Virus in Chimeric Mice by Short Synthetic Hairpin RNAs: Sequence Analysis of Surviving Virus Shows Added Selective Pressure of Combination Therapy
Anne Dallas et al.
JOURNAL OF VIROLOGY (2014)
Development and function of human innate immune cells in a humanized mouse model
Anthony Rongvaux et al.
NATURE BIOTECHNOLOGY (2014)
Treatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin
Jordan J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Extensive double humanization of both liver and hematopoiesis in FRGN mice
Elizabeth M. Wilson et al.
STEM CELL RESEARCH (2014)
Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization
Koen Vercauteren et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
Moses T. Bility et al.
PLOS PATHOGENS (2014)
A Translational Study of Resistance Emergence Using Sequential Direct-Acting Antiviral Agents for Hepatitis C Using Ultra-Deep Sequencing
Hiromi Abe et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2013)
A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections
Keiichi Kosaka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity
Craig A. Coburn et al.
CHEMMEDCHEM (2013)
Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice
Niu Shi et al.
GUT (2013)
The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from the Los Alamos databank
R. Alves et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
Marcus Dorner et al.
NATURE (2013)
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses
Abeba Tesfaye et al.
PLOS ONE (2013)
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
Michael J. Fuller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
Alexander Vogt et al.
VIROLOGY (2013)
Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naive patients
Stefania Paolucci et al.
VIROLOGY JOURNAL (2013)
Hepatitis C virus infection and related liver disease: the quest for the best animal model
Laurent Mailly et al.
FRONTIERS IN MICROBIOLOGY (2013)
Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus
Angela M. Lam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor
Zulema Plaza et al.
ANTIVIRAL THERAPY (2012)
A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes
Sibylle Haid et al.
GASTROENTEROLOGY (2012)
A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
Philip Meuleman et al.
HEPATOLOGY (2012)
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
Noemie Calland et al.
HEPATOLOGY (2012)
Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
Viet Loan Dao Thi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Hepatitis C Viral Evolution in Genotype 1 Treatment-Naive and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials
Tara L. Kieffer et al.
PLOS ONE (2012)
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
Erick Giang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
Trevor J. Morin et al.
PLOS PATHOGENS (2012)
Sustained Viral Response in a Hepatitis C Virus-Infected Chimpanzee via a Combination of Direct-Acting Antiviral Agents
David B. Olsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Protease Inhibitor-Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
Tetsuro Shimakami et al.
GASTROENTEROLOGY (2011)
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
Michael L. Washburn et al.
GASTROENTEROLOGY (2011)
The Green Tea Polyphenol, Epigallocatechin-3-Gallate, Inhibits Hepatitis C Virus Entry
Sandra Ciesek et al.
HEPATOLOGY (2011)
Impact of Viral Amino Acid Substitutions and Host Interleukin-28B Polymorphism on Replication and Susceptibility to Interferon of Hepatitis C Virus
Nobuhiko Hiraga et al.
HEPATOLOGY (2011)
Rapid Emergence of Telaprevir Resistant Hepatitis C Virus Strain from Wildtype Clone In Vivo
Nobuttiko Hiraga et al.
HEPATOLOGY (2011)
In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C Virus
Philip Meuleman et al.
HEPATOLOGY (2011)
Genotypic and Phenotypic Analysis of Variants Resistant to Hepatitis C Virus Nonstructural Protein 5A Replication Complex Inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
Robert A. Fridell et al.
HEPATOLOGY (2011)
Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice
Ype P. de Jong et al.
JOURNAL OF HEPATOLOGY (2011)
Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice
Eiji Ohara et al.
JOURNAL OF HEPATOLOGY (2011)
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors
S. Franco et al.
JOURNAL OF VIRAL HEPATITIS (2011)
A genetically humanized mouse model for hepatitis C virus infection
Marcus Dorner et al.
NATURE (2011)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Assembly of infectious hepatitis C virus particles
Ralf Bartenschlager et al.
TRENDS IN MICROBIOLOGY (2011)
Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success
Rineke H. G. Steenbergen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
Antonio Ascione et al.
GASTROENTEROLOGY (2010)
Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
Christoph Sarrazin et al.
GASTROENTEROLOGY (2010)
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
Karl-Dimiter Bissig et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Positive Selection of Core 70Q Variant Genotype 1b Hepatitis C Virus Strains Induced by Pegylated Interferon and Ribavirin
Fuat Kurbanov et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Pathogenesis of Hepatitis C Virus Infection in Tupaia belangeri
Yutaka Amako et al.
JOURNAL OF VIROLOGY (2010)
Species-Specific Regions of Occludin Required by Hepatitis C Virus for Cell Entry
Maria L. Michta et al.
JOURNAL OF VIROLOGY (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
Julia Bitzegeio et al.
PLOS PATHOGENS (2010)
Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees
Steven S. Carroll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women
Peter D. Dryer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
Jose M. Cuevas et al.
JOURNAL OF VIROLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In Vivo
Philip Meuleman et al.
HEPATOLOGY (2008)
Naturally Occurring Dominant Resistance Mutations to Hepatitis C Virus Protease and Polymerase Inhibitors in Treatment-Naive Patients
Thomas Kuntzen et al.
HEPATOLOGY (2008)
Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3•4A protease inhibitors in treatment-naive subjects
Doug J. Bartels et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model
Karl-Dimiter Bissig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model
Chih-Ming Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma
Xinping Xu et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice
Hisaya Azuma et al.
NATURE BIOTECHNOLOGY (2007)
Novel robust hepatitis C virus mouse efficacy model
Qing Zhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The hepatitis C virus and immune evasion:: nonstructural 3/4A transgenic mice are resistant to lethal tumour necrosis factor α mediated liver disease
L. Frelin et al.
GUT (2006)
Expression of hepatitis C virus nonstructural 4B in transgenic mice
Ai-Guo Wang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application
Norman M. Kneteman et al.
HEPATOLOGY (2006)
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
BD Lindenbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): A potential treatment to prevent HCV reinfection in liver transplant patients
R Eren et al.
JOURNAL OF VIROLOGY (2006)
Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins
M Nakagawa et al.
GASTROENTEROLOGY (2005)
A novel immunocompetent rat model of HCV infection and hepatitis
GY Wu et al.
GASTROENTEROLOGY (2005)
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera
P Meuleman et al.
HEPATOLOGY (2005)
A critical role for the chimpanzee model in the study of hepatitis C
J Bukh
HEPATOLOGY (2004)
Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice
M Majumder et al.
FEBS LETTERS (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus
H Lerat et al.
GASTROENTEROLOGY (2002)
The hepatitis C virus (HCV)-Trimera mouse: A model for evaluation of agents against HCV
E Ilan et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Hepatitis C virus replication in mice with chimeric human livers
DF Mercer et al.
NATURE MEDICINE (2001)
分享论文
